
TY  - JOUR
AU  - Inukai, Takeshi
AU  - Zhang, Xiuru
AU  - Kameyama, Takeshi
AU  - Suzuki, Yukiko
AU  - Yoshikawa, Kazuhito
AU  - Kuroda, Itaru
AU  - Nemoto, Atsushi
AU  - Akahane, Koshi
AU  - Sato, Hiroki
AU  - Goi, Kumiko
AU  - Nakamoto, Kazunori
AU  - Hamada, Jun-ichi
AU  - Tada, Mitsuhiro
AU  - Moriuchi, Tetsuya
AU  - Sugita, Kanji
TI  - A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21738
DO  - doi:10.1002/ajh.21738
SP  - 535
EP  - 537
PY  - 2010
ER  - 

TY  - JOUR
TI  - Plenary Session
JO  - Epilepsia
VL  - 47
IS  - s4
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2006.00001_12.x
DO  - doi:10.1111/j.1528-1167.2006.00001_12.x
SP  - 377
EP  - 377
PY  - 2006
AB  - 1 Elson L. So ( 1 Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN ) Some seizure disorders are known to be associated with excess mortality, and persons with epilepsy have been reported to have shorter life expectancies. Furthermore, concerted attention from both clinicians and researchers is needed to address the catastrophic condition of sudden unexplained death in epilepsy (SUDEP). This program will identify epileptic conditions that are associated with increased risks for death, so that measures can be formulated and applied to reduce the risks. The necessity and the implications of counseling patients about the risk of SUDEP will also be discussed.
ER  - 

TY  - JOUR
AU  - van Tuijn, Charlotte F.J.
AU  - van Beers, Eduard J.
AU  - Schnog, John-John B.
AU  - Biemond, Bart J.
TI  - Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21731
DO  - doi:10.1002/ajh.21731
SP  - 532
EP  - 535
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Sessions 1-9
JO  - Transplant International
VL  - 18
IS  - s1
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2005.18s1_001.x
DO  - doi:10.1111/j.1432-2277.2005.18s1_001.x
SP  - 2
EP  - 17
PY  - 2005
ER  - 

TY  - JOUR
AU  - Huang, Jiajia
AU  - Lin, Tongyu
AU  - Li, Zhi-Ming
AU  - Xu, Ruihua
AU  - Huang, Huiqiang
AU  - Jiang, Wenqi
TI  - Primary pulmonary non-Hodgkin's lymphoma: A retrospective analysis of 29 cases in a Chinese population
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21720
DO  - doi:10.1002/ajh.21720
SP  - 523
EP  - 525
PY  - 2010
ER  - 

TY  - JOUR
AU  - Viswabandya, Auro
AU  - Baidya, Shoma
AU  - Nair, Sukesh C.
AU  - Lakshmi, Kavitha M.
AU  - Mathews, Vikram
AU  - George, Biju
AU  - Chandy, Mammen
AU  - Srivastava, Alok
TI  - Clinical manifestations of combined factor V and VIII deficiency: A series of 37 cases from a single center in India
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21741
DO  - doi:10.1002/ajh.21741
SP  - 538
EP  - 539
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 60
IS  - S2
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.16336
DO  - doi:10.1111/epi.16336
SP  - 5
EP  - 248
PY  - 2019
ER  - 

TY  - JOUR
AU  - Deambrogi, Clara
AU  - De Paoli, Lorenzo
AU  - Fangazio, Marco
AU  - Cresta, Stefania
AU  - Rasi, Silvia
AU  - Spina, Valeria
AU  - Gattei, Valter
AU  - Gaidano, Gianluca
AU  - Rossi, Davide
TI  - Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21742
DO  - doi:10.1002/ajh.21742
SP  - 541
EP  - 544
PY  - 2010
ER  - 

TY  - JOUR
AU  - Csaszar, Elizabeth
AU  - Cohen, Sandra
AU  - Zandstra, Peter W.
TI  - Blood stem cell products: Toward sustainable benchmarks for clinical translation
JO  - BioEssays
JA  - Bioessays
VL  - 35
IS  - 3
SN  - 0265-9247
UR  - https://doi.org/10.1002/bies.201200118
DO  - doi:10.1002/bies.201200118
SP  - 201
EP  - 210
KW  - bioengineering
KW  - hematopoietic stem cell transplantation
KW  - in vitro expansion
KW  - umbilical cord blood
PY  - 2013
AB  - Abstract Robust ex vivo expansion of umbilical cord blood (UCB) derived hematopoietic stem and progenitor cells (HSPCs) should enable the widespread use of UCB as a source of cells to treat hematologic and immune diseases. Novel approaches for HSPC expansion have recently been developed, setting the stage for the production of blood stem cell derived products that fulfill our current best known criteria of clinical relevance. Translating these technologies into clinical use requires bioengineering strategies to overcome challenges of scale-up, reproducibility, and product quality assurance. Clinical-scale implementation should also define criteria and targets for cost-effective cell manufacturing. As production strategies become more effective, new opportunities in the therapeutic use of ex vivo expanded hematopoietic cell products will emerge. Herein we examine key technological milestones that need to be met in order to move ex vivo expanded HSPC therapies from the bench-top to the bedside in a robust and reliable manner.
ER  - 

TY  - JOUR
AU  - Racil, Zdenek
AU  - Razga, Filip
AU  - Buresova, Lucie
AU  - Jurcek, Tomas
AU  - Dvorakova, Dana
AU  - Zackova, Daniela
AU  - Timilsina, Shira
AU  - Cetkovsky, Petr
AU  - Mayer, Jiri
TI  - The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21722
DO  - doi:10.1002/ajh.21722
SP  - 525
EP  - 528
PY  - 2010
ER  - 

TY  - JOUR
AU  - Frey, Noelle V.
AU  - Porter, David L.
TI  - Hematopoietic stem cell transplantation: ASBMT/CIBMTR 2010 tandem meeting highlights and discussion
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 85
IS  - 7
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.21744
DO  - doi:10.1002/ajh.21744
SP  - 519
EP  - 523
PY  - 2010
ER  - 

TY  - JOUR
TI  - Pediatric State of the Art Symposium
JO  - Epilepsia
VL  - 47
IS  - s4
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2006.00001_11.x
DO  - doi:10.1111/j.1528-1167.2006.00001_11.x
SP  - 377
EP  - 377
PY  - 2006
AB  - 1 Ajay Gupta, and 2 Mohamad Mikati ( 1 Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH ; and 2 Department of Neurology, American University of Beirut, Beirut, Lebanon ) There is a unique, apparently heterogeneous, group of epilepsy syndromes in children that is characterized by sleep activation of the epileptiform abnormalities with nearly continuous sharp waves seen on the scalp EEG during sleep. These include commonly recognized childhood conditions such as Landau-Kleffner syndrome (LKS), electrical status epilepticus in slow wave sleep (ESES), and benign rolandic epilepsy of childhood (BREC). Most of these children have a period of normal development and healthy childhood. Besides presenting with seizures that are often not too difficult to treat, these children have other major cognitive, behavioral and academic difficulties that are disproportionate to the burden of epilepsy and medications used to treat them. It is commonly believed that abnormal electrical activity in sleep per se leads to cognitive, behavioral, and academic difficulties in these children. However, the pathophysiological understanding of this phenomenon of sleep activation and its clinical implications are poorly understood. Moreover, there are also controversies regarding terminology, classification, and management of these disorders. Some experts believe that these conditions are distinct disease entities while others hypothesize that they may represent a spectrum of one condition. Similar sleep activation of epileptic discharges has also been reported in some other children with neuroimaging abnormalities in the deep gray nuclei. Some experts believe that the treatment with antiepileptic medications in these children should be titrated to the EEG response in sleep and not to the clinical response of seizures. It is unclear as to how often a sleep EEG should be done, and to what extent aggressive medical treatment and antiepileptic polytherapy be pursued. Use of steroids, recent success with high dose nightly benzodiazepine therapy, and surgical procedure like multiple subpial transactions in the insular regions continue to be controversial due to risk of serious side effects and modest benefits in reported anecdotal case reports and series. The focus of this symposium is to revisit these syndromes to: a) define the clinical spectrum of these conditions; b) formulate the best practices for management in the light of controversies in medical and surgical options; and c) discuss possible pathophysiological mechanisms underlying these disorders and probe future strategies for better treatment. Margret Shouse will show similarities between kindled epileptic kittens and sleep activation of EEG in children with these conditions. She will review the potential mechanisms and generators of EEG activity during sleep, discuss how the cognitive and behavioral sequelae may occur regardless of severe seizure burden. Edouard Hirsch will discuss the available clinical evidence to suggest that these ?disorders may be a clinical spectrum of one condition? and not distinct disease entities. He will also discuss diagnostic criteria and role of neuroimaging. Jim Rivello will review the available evidence, and emphasize the best clinical practices for management in these children. First, he will discuss the goals of treatment i.e. seizure control, behavior improvement, cognition monitoring, and sleep EEG improvement. Second, he will formulate a treatment and follow-up plan with indications for various medical (anti epileptic agents, steroids, nightly benzodiazepenes etc.) and surgical (multiple subpial transactions) options. Each speaker will also formulate an important research question for the future that will improve our understanding of these conditions for devising better treatment methods. Live interaction with the diverse group of audience will also provide a forum to discuss where and how we should move forward with a collaborative effort for advancing our knowledge and treatment of these conditions.
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 62
IS  - s1
SN  - 0002-8614
UR  - https://doi.org/10.1111/jgs.12870
DO  - doi:10.1111/jgs.12870
SP  - S1
EP  - S331
PY  - 2014
ER  - 

TY  - JOUR
TI  - Index of biochemical reviews
JO  - FEBS Letters
VL  - 268
IS  - S1
SN  - 0014-5793
UR  - https://doi.org/10.1016/0014-5793(90)80357-O
DO  - doi:10.1016/0014-5793(90)80357-O
SP  - 1
EP  - 188
PY  - 1990
ER  - 

TY  - JOUR
TI  - 21st IEC Proceedings
JO  - Epilepsia
VL  - 36
IS  - s3
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1157.1995.tb01719.x
DO  - doi:10.1111/j.1528-1157.1995.tb01719.x
SP  - S1
EP  - S275
PY  - 1995
ER  - 

TY  - JOUR
TI  - Poster Session: Haemostasis and Thrombosis
JO  - British Journal of Haematology
VL  - 149
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2010.08116_1.x
DO  - doi:10.1111/j.1365-2141.2010.08116_1.x
SP  - 27
EP  - 96
PY  - 2010
ER  - 

TY  - JOUR
TI  - Sunday, December 6, 2009 Poster Session 2 8:00 a.m.-6:00 p.m.
JO  - Epilepsia
VL  - 50
IS  - s11
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1167.2009.02377_3.x
DO  - doi:10.1111/j.1528-1167.2009.02377_3.x
SP  - 158
EP  - 308
PY  - 2009
ER  - 

TY  - JOUR
TI  - 12 — Inhibitors
JO  - Haemophilia
VL  - 10
IS  - s3
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2004.00972.x
DO  - doi:10.1111/j.1365-2516.2004.00972.x
SP  - 53
EP  - 66
PY  - 2004
ER  - 

TY  - JOUR
TI  - Presented at the 24th Congress of the International Society of Haematology, London, 23–27 August 1992
JO  - British Journal of Haematology
VL  - 82
IS  - 1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.1992.tb04620.x
DO  - doi:10.1111/j.1365-2141.1992.tb04620.x
SP  - 273
EP  - 286
PY  - 1992
ER  - 

TY  - JOUR
TI  - Abstracts of the ESRS, Prague 2004
JO  - Journal of Sleep Research
VL  - 13
IS  - s1
SN  - 0962-1105
UR  - https://doi.org/10.1111/j.1365-2869.2004.00410.x
DO  - doi:10.1111/j.1365-2869.2004.00410.x
SP  - 1
EP  - 832
PY  - 2004
ER  - 
